Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection

The CETP inhibitor, torcetrapib, was prematurely terminated from phase 3 clinical trials due to an increase in cardiovascular and noncardiovascular mortality. Because nearly half of the latter deaths involved patients with infection, we have tested torcetrapib and other CETPIs to see if they interfe...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Clark, Ronald W., Cunningham, David, Cong, Yang, Subashi, Timothy A., Tkalcevic, George T., Lloyd, David B., Boyd, James G., Chrunyk, Boris A., Karam, George A., Qiu, Xiayang, Wang, Ing-Kae, Francone, Omar L.
Format: Artigo
Langue:Inglês
Publié: The American Society for Biochemistry and Molecular Biology 2010
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2853464/
https://ncbi.nlm.nih.gov/pubmed/19965592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M002295
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires